Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2123 of 6351
-
Can a Lung-Opening maneuver change a key injury marker in ARDS?
Knowledge-focused CompletedRAGE, the receptor for advanced glycation end products, is a novel marker of alveolar epithelial type I cell injury, and soluble RAGE (sRAGE) is elevated in the plasma and in the pulmonary edema fluid from patients with ALI/ARDS. Few data are available about the influence of vent…
Phase 4 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
New PET scan could reveal kidney cancer drug success in weeks, not months
Diagnosis OngoingUsually, doctors monitor kidney cancer with CT scans to measure the size of tumors. Sometimes, even when a drug is working, it can take several months before the effects are seen on a regular CT scan. The purpose of this study is to see if a new kind of scan, called 124I-cG250 PE…
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Diagnosis
Last updated Jul 10, 2026 00:00 UTC
-
Can a Book-Based support group tame hoarding?
Symptom relief OngoingThe proposed study aims to investigate the efficacy of a facilitated self-help group for the treatment of hoarding disorder. Eligible participants will take part in a facilitated self-help group. The investigators aim to investigate the effects of a self-help group on hoarding sy…
Sponsor: University of Miami • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC
-
New drug shows promise for aggressive leukemia but carries serious clot risk
Disease control Stopped earlyThe goal of this clinical research study is to learn if ponatinib can help to control Chronic Myeloid Leukemia (CML) in accelerated phase. The safety of this drug will also be studied. Ponatinib is designed to block the function of BCR-ABL, which is the abnormal protein responsi…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Can a common drug boost brain function in kids with rare genetic disorder?
Disease control CompletedAn exploratory phase 2 therapeutic trial in children from 6 to 21, RTS carriers, randomized to be treated either with sodium valproate with the usual pediatric dosage (30 mg/kg/j), or by placebo for one year. The investigator would like to include children because they could bes…
Phase 2 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New drug combo tested to stop prostate cancer spread before surgery
Disease control CompletedThis randomized phase IIA trial studies how well antiandrogen therapy works with or without axitinib before surgery in treating patients with previously untreated prostate cancer that is known or suspected to have spread to lymph nodes. Androgens can cause the growth of prostate …
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Can a simple mouthwash silence sensitive teeth?
Symptom relief CompletedThe aim of this study is to evaluate the clinical efficacy of two experimental mouthwash formulations, against a placebo mouthwash (without experimental ingredients). One experimental formulation to be used either once daily or twice daily, and the second experimental formulation…
Sponsor: HALEON • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
Could painkillers quietly disrupt your hormones?
Knowledge-focused CompletedChronic pain is often associated with a chronic stress and HHSG axis plays a pivotal role in maintaining homeostasis. The literature reports that pain in patients treated with opioids, significant changes are taking place in this axis with a collapse in hormone concentrations tha…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
New hope for kids with Crohn's: drug shows promise in small trial
Disease control CompletedThe purpose of this study is to evaluate the efficacy of TA-650 using Pediatric Crohn's Disease Activity Index (PCDAI) in pediatric patients with moderate to severe Crohn's disease after TA-650 administration at a dose of 5 mg/kg at week 0, 2, and 6, then every 8 week after week …
Phase 3 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New cocktail aims to wipe out CLL early
Disease control CompletedIn previously-untreated subjects with CLL, fludarabine and rituximab with or without cyclophosphamide (FR or FCR) produces complete responses (CR) of 40-80%. The major complication of FCR has been grade 3/4 neutropenia which was reduced using a lower dose of fludarabine and cyclo…
Phase 2 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New cocktail of old drugs shows promise for tough blood cancers
Disease control Recruiting nowThe goal of this clinical research study is to learn if cladribine given in combination with low-dose cytarabine (LDAC) and decitabine can help control the disease in patients with AML or MDS. The safety of this drug combination will also be studied. Cladribine is designed to in…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Norwegian study reveals best bariatric surgery for lasting weight loss
Disease control CompletedBariatric surgery of morbid obesity was first located at Førde Central Hospital, but it is now an established treatment at several other hospitals in the health region (Voss Hospital (Helse Bergen), Haugesund Hospital (Helse Fonna) Stavanger University Hospital ((SUS) Helse Stava…
Sponsor: Helse Fonna • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New hope for kids with severe colitis: drug shows promise in small trial
Disease control CompletedThe purpose of this study is to evaluate the the efficacy of TA-650 using Clinical activity index (CAI) score and other evaluation indicators in pediatric patients with moderate to severe ulcerative colitis after TA-650 administration of at a dose of 5 mg/kg at weeks 0, 2, and 6,…
Phase 3 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New stent grafts aim to fix aortic aneurysms without major surgery
Disease control Recruiting nowZenith t-Branch Study Cohort: The purpose of this study is to collect information on the Cook Zenith t-Branch endovascular stent-graft system and the Terumo Arch Branch for the treatment of aortic aneurysms. Terumo Arch Branch Study Cohort: The purpose of this additional study a…
Sponsor: Baptist Health South Florida • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can yearly Check-Ups unlock COPD's hidden patterns?
Knowledge-focused CompletedThe Time-based Register and Analysis of COPD Endpoints (TRACE) study is prospective cohort study aiming at evaluating COPD patients using simple basic tools normally used in the clinic at hand of any physician. The objective of the study is to accomplish specific aims. 1) describ…
Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Blood type no barrier? study tests liver transplant success across ABO barriers
Knowledge-focused By invitation onlyThis retrospective cohort study aimed to evaluate long-term oncologic outcomes after ABO-incompatible living donor liver transplantation (LDLT) for hepatocellular carcinoma (HCC). Patients who underwent LDLT between January 2012 and December 2023 at a single tertiary center were …
Sponsor: Seoung Hoon Kim • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
Can new techniques safely unblock the Heart's most stubborn clogs?
Knowledge-focused Recruiting nowPercutaneous coronary intervention (PCI) of chronic total occlusions (CTOs) is increasingly being performed in patients with advanced coronary artery disease, but there is limited information on the techniques utilized and the procedural outcomes. The goal of this multicenter, in…
Sponsor: Minneapolis Heart Institute Foundation • Aim: Knowledge-focused
Last updated Aug 21, 2026 00:00 UTC
-
Exercise program aims to steady the steps of Parkinson's patients
Disease control CompletedThe primary objective of this study is to investigate the effects of a theoretically driven, highly challenging exercise program (balance and strengthening exercises) in reducing fall rate, improving balance and reducing fear of falling in persons with Parkinson's disease. In th…
Sponsor: Boston University Charles River Campus • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Can a blood marker tell fever from infection in stroke?
Knowledge-focused CancelledApproximately 12% of strokes in the United States are hemorrhagic.1 Hemorrhagic stroke can lead to multiple complications including fever that is not infectious. Identifying the cause of fever can help physicians choose the best care for the patient to try and prevent further dam…
Sponsor: CAMC Health System • Aim: Knowledge-focused
Last updated Aug 23, 2026 00:00 UTC
-
Can tracking early COPD reveal ways to halt its progression?
Knowledge-focused By invitation onlyThe KOrea COpd Subgroup Study team (KOCOSS) cohort is an ongoing, longitudinal, prospective, non-interventional and observational study within the Korean COPD patients. The prevalence of early COPD (mild to moderate COPD based by 2011 GOLD(the Global Initiative for Chronic Obstru…
Sponsor: Konkuk University Medical Center • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC